@article{01KBJ8A73HYA4BXY371R5X80D0,
  abstract     = {{Objectives As (a lack of) vitamin D has been linked to a wide variety of chronic diseases, there is growing interest in generating robust epidemiological data. Consequently, the need for large-scale biological sample collection has increased. In this context, dried blood spot (DBS) microsampling offers a minimally invasive alternative to venous sampling. However, to allow interpretation of DBS-based 25-hydroxyvitamin D (25-(OH)D) results, the set-up of a clinical validation study is essential to assess the agreement with the reference matrix, plasma.Methods Venous plasma and whole blood, venous DBS (vDBS) and capillary DBS (cDBS) were collected from 44 healthy volunteers to evaluate the agreement between the different sample types for 25-(OH)D quantification. To transform cDBS-based results to plasma concentrations, a hematocrit (Hct)-dependent conversion factor was applied and evaluated using four different Hct determination approaches. All samples were analysed using previously described validated LC-MS/MS methods.Results No clinically relevant methodological (vDBS vs. whole blood) or sampling-site related (cDBS vs. vDBS) issues were observed. Following Hct-dependent conversion, good agreement between the cDBS-derived and actually measured plasma results was obtained, as 90 % of the results lay within 20 % of the plasma result, independent of the Hct approach used. Additionally, weighted Cohen's kappa values of 0.83-0.85 were obtained across the different Hct approaches, indicating substantial to almost perfect agreement in vitamin D status classification.Conclusions Following Hct-dependent conversion, cDBS can be used as a reliable and practical alternative matrix to plasma for large-scale monitoring of vitamin D status in epidemiological and public health contexts.}},
  author       = {{Heughebaert, Liesl and Ghesquière, Rosalie and Stove, Christophe}},
  issn         = {{1434-6621}},
  journal      = {{CLINICAL CHEMISTRY AND LABORATORY MEDICINE}},
  keywords     = {{25-hydroxyvitamin D,clinical validation,dried blood spots,LC-MS/MS,hematocrit,DRIED BLOOD SPOTS,VITAMIN-D,D-3,SERUM,QUANTIFICATION}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{866--879}},
  title        = {{Clinical validation of a DBS-based LC-MS/MS method for 25-hydroxyvitamin D : from lab sampling to home sampling}},
  url          = {{http://doi.org/10.1515/cclm-2025-1002}},
  volume       = {{64}},
  year         = {{2026}},
}

Altmetric

View in Altmetric

Web of Science

Times cited: